U.S. military jets on Saturday intercepted a civilian aircraft that flew through temporarily restricted airspace over Palm Beach, Florida, where President Trump's Mar-a-Lago estate is located, ...

The grocery store formerly known as Steve’s 9th Street Supermarket in Park Slope has a new occupant. K Slope Market, a full-service supermarket and member of the Key Food Cooperative, opened its doors ...

After half a decade of stagnant grids without any major team changes, Formula 1 is about to get two big new automakers at once. One is Cadillac, the American entrant building a new team from the ...

Once again, Israeli bombs rained down on Gaza. The latest wave of strikes killed more than 100 people, mostly women and children, according to health authorities. The bombardment marked the deadliest ...

Crew members on flotilla vessel Conscience after intercepted by Israeli forces A new flotilla heading for the Gaza Strip with food and medical supplies on board has been intercepted by Israeli forces.

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

A federal judge in San Francisco on Wednesday temporarily blocked a federal administrative subpoena aimed at unmasking Instagram accounts that named and shamed a Border Patrol agent who was part of ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...